22 First interim analysis of a randomized trial comparing capecitabine/epirubicin/cyclophosphamide (XEC) vs 5-FU/epirubicin/cyclophosphamide (FEC) as adjuvant therapy for medium- or high-risk early breast cancer (EBC)

✍ Scribed by Z. Shao; B. Huang; J. Zhang; S. Zhou; P. He; D. Chen; S. Cui; C. Ren; L. Cai; J. Shi

• Book ID: 119601039
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 49 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)70053-7